首页 > 市场调查报告书 > 製药

药物开发

市场调查报告书

商品编码

1550158

药物发现技术

Drug Discovery Technologies

出版日期: 2024年09月04日 | 出版商:

BCC Research | 英文 192 Pages | 订单完成后即时交付

价格

简介目录图表

全球药物发现技术市场规模预计将从 2024 年的1,119 亿美元增至 2029 年底的 1,970 亿美元，预测期内复合年增长率为 12.0%。

生物分析仪器产业预计将从2024年的300亿美元成长到2029年终的503亿美元，复合年增长率为10.9%。此外，高通量筛检产业预计将从 2024 年的 250 亿美元成长到 2029年终的439 亿美元，复合年增长率为 11.9%。

该报告调查了全球药物发现技术市场，并提供了市场概况、市场影响因素和市场机会分析、新兴技术和技术发展趋势、市场规模趋势和预测，以及各个细分市场和地区的详细分析、竞争格局。

市场动态
市场驱动因素
药物发现中的高内涵筛检（HCS）技术
技术进步
个性化医疗需求
慢性病和免疫疾病盛行率上升
老年人口增加
研究经费的可用性
市场限制因素
药物发现过程和设备成本
严格规定
更深入了解分子机制
市场机会
人工智慧在药物发现的潜力

第四章新兴技术

概述
AI

第五章市场区隔分析

细分细分
全球药物发现技术市场：依技术分类
全球市场预测
高通量筛检（HTS）
生物分析设备
基因组学
蛋白质体学
基于细胞的测定和试剂
生物资讯学
其他的
全球药物发现技术市场：依疾病分类
全球市场规模及预测
瘤
心臟病
神经退化性疾病
免疫疾病
其他的
全球药物发现技术市场：按最终用户划分
全球市场规模及预测
生物製药公司
研究/学术
CRO
地域分布
全球药物发现技术市场：按地区划分
全球市场规模及预测
北美洲
欧洲
亚太地区
其他的

第六章竞争讯息

竞争格局
公司市场占有率分析
SWOT分析

第七章给药技术市场的永续性：ESG 视角

ESG：简介
药物发现技术产业的永续性
ESG观点
环境影响
社会影响
管治影响

第8章附录

调查方法
简称
来源
公司简介
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
DANAHER CORP.
ILLUMINA INC.
PROMEGA CORP.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.

简介目录图表

Product Code: BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

The bioanalytical instruments market for drug discovery technologies is expected to grow from $30.0 billion in 2024 and is projected to reach $50.3 billion by the end of 2029, at a CAGR of 10.9% during the forecast period of 2024 to 2029.

The high-throughput screening market for drug discovery technologies is expected to grow from $25.0 billion in 2024 and is projected to reach $43.9 billion by the end of 2029, at a CAGR of 11.9% during the forecast period of 2024 to 2029.

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies' current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.

The report's goals include:

Analyzing technologies and applications.
Analyzing global market size and segmentation.
Identifying market constraints and drivers.
Providing detailed market forecasts through 2029.
Assessing market shares, competitiveness, and industry structure.
Identifying potential long-term impacts on the drug discovery technologies market.

Report Includes:

104 data tables and 34 additional tables
An analysis of the current and future global markets for drug discovery technologies
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
Discussion of bioinformatics as a platform for drug discovery
A comparison between proteomics and genomics drug discovery technology
Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
High-Content Screening (HCS) Techniques in Drug Discovery
Technological Advances
Demand for Personalized Medicine
Rising Prevalence of Chronic and Immunological Diseases
Growing Elderly Population
Availability of Research Funds
Market Restraints
Cost of the Drug Discovery Process and Instruments
Stringent Regulations
Better Understanding of Molecular Mechanisms
Market Opportunities
Potential for AI in Drug Discovery

Chapter 4 Emerging Technologies

Overview
AI

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Global Market for Drug Discovery Technologies, by Technology
Global Market Forecast
High-Throughput Screening (HTS)
Bioanalytical Instruments
Genomics
Proteomics
Cell-Based Assays and Reagents
Bioinformatics
Other Technologies
Market for Drug Discovery Technologies, by Disease Application
Global Market Size and Forecast
Oncology
Cardiology
Neurodegenerative Diseases
Immunological Diseases
Other Diseases
Global Market for Drug Discovery Technologies, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Research and Academia
Contract Research Organizations (CROs)
Geographic Breakdown
Global Market for Drug Discovery Technologies, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World

Chapter 6 Competitive Intelligence

Competitive Landscape
Analysis of Companies' Market Shares
SWOT Analysis
Strengths
Challenges
Opportunities
Threats

Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective

Introduction to ESG
Sustainability in the Drug Discovery Technologies Industry
ESG Perspective
Environmental Impact
Social Impact
Governance Impact

Chapter 8 Appendix

Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
DANAHER CORP.
ILLUMINA INC.
PROMEGA CORP.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.

简介目录图表

List of Tables

Summary Table : Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 1 : Porter's Five Forces Analysis of the Drug Discovery Technologies Market
Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2021-2045
Table 3 : Global Prevalence of Multiple Sclerosis, by WHO Region, 2013 and 2020
Table 4 : Global HIV Epidemic, by Age Group, 2023
Table 5 : Global Population Growth, by Age Group, Through 2050
Table 6 : Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 7 : Global Market for HTS in Drug Discovery, by Region, Through 2029
Table 8 : Global Market for Bioanalytical Instruments in Drug Discovery, by Product Type, Through 2029
Table 9 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, Through 2029
Table 10 : Global Market for Genomics in Drug Discovery, by Product Type, Through 2029
Table 11 : Global Market for Genomics in Drug Discovery, by Region, Through 2029
Table 12 : Protein Microarrays and Their Functions
Table 13 : Global Market for Proteomics in Drug Discovery, by Product Type, Through 2029
Table 14 : Global Market for Proteomics in Drug Discovery, by Region, Through 2029
Table 15 : Cell Biology Reagents and Their Functions
Table 16 : Global Market for Cell-Based Assays and Reagents in Drug Discovery, by Product Type, Through 2029
Table 17 : Global Market for Cell-based Assays and Reagents in Drug Discovery, by Region, Through 2029
Table 18 : Global Market for Bioinformatics in Drug Discovery, by Region, Through 2029
Table 19 : Comparison of Solid-Phase and Solution-Phase Synthesis
Table 20 : Global Market for Other Technologies in Drug Discovery, by Region, Through 2029
Table 21 : Global Market for Drug Discovery Technologies, by Application, Through 2029
Table 22 : Global Market for Drug Discovery Technologies in Oncology, by Region, Through 2029
Table 23 : Global Market for Drug Discovery Technologies in Cardiology, by Region, Through 2029
Table 24 : Global Market for Drug Discovery Technologies in Neurodegenerative Diseases, by Region, Through 2029
Table 25 : Global Market for Drug Discovery Technologies in Immunological Diseases, by Region, Through 2029
Table 26 : Global Market for Drug Discovery Technologies in Other Diseases, by Region, Through 2029
Table 27 : Global Market for Drug Discovery Technologies, by End User, Through 2029
Table 28 : Global Market for Drug Discovery Technologies in Biopharma Companies, by Region, Through 2029
Table 29 : Global Market for Drug Discovery Technologies in Research and Academia, by Region, Through 2029
Table 30 : Global Market for Drug Discovery Technologies in CROs, by Region, Through 2029
Table 31 : Global Market for Drug Discovery Technologies, by Region, Through 2029
Table 32 : North American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 33 : North American Market for Drug Discovery Technologies, by Application, Through 2029
Table 34 : North American Market for Drug Discovery Technologies, by End User, Through 2029
Table 35 : North American Market for Drug Discovery Technologies, by Country, Through 2029
Table 36 : U.S. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 37 : U.S. Market for Drug Discovery Technologies, by Application, Through 2029
Table 38 : U.S. Market for Drug Discovery Technologies, by End User, Through 2029
Table 39 : Canadian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 40 : Canadian Market for Drug Discovery Technologies, by Application, Through 2029
Table 41 : Canadian Market for Drug Discovery Technologies, by End User, Through 2029
Table 42 : Mexican Market for Drug Discovery Technologies, by Technology, Through 2029
Table 43 : Mexican Market for Drug Discovery Technologies, by Application, Through 2029
Table 44 : Mexican Market for Drug Discovery Technologies, by End User, Through 2029
Table 45 : European Market for Drug Discovery Technologies, by Technology, Through 2029
Table 46 : European Market for Drug Discovery Technologies, by Application, Through 2029
Table 47 : European Market for Drug Discovery Technologies, by End User, Through 2029
Table 48 : European Market for Drug Discovery Technologies, by Country, Through 2029
Table 49 : German Market for Drug Discovery Technologies, by Technology, Through 2029
Table 50 : German Market for Drug Discovery Technologies, by Application, Through 2029
Table 51 : German Market for Drug Discovery Technologies, by End User, Through 2029
Table 52 : U.K. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 53 : U.K. Market for Drug Discovery Technologies, by Application, Through 2029
Table 54 : U.K. Market for Drug Discovery Technologies, by End User, Through 2029
Table 55 : French Market for Drug Discovery Technologies, by Technology, Through 2029
Table 56 : French Market for Drug Discovery Technologies, by Application, Through 2029
Table 57 : French Market for Drug Discovery Technologies, by End User, Through 2029
Table 58 : Italian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 59 : Italian Market for Drug Discovery Technologies, by Application, Through 2029
Table 60 : Italian Market for Drug Discovery Technologies, by End User, Through 2029
Table 61 : Spanish Market for Drug Discovery Technologies, by Technology, Through 2029
Table 62 : Spanish Market for Drug Discovery Technologies, by Application, Through 2029
Table 63 : Spanish Market for Drug Discovery Technologies, by End User, Through 2029
Table 64 : Rest of Europe Market for Drug Discovery Technologies, by Technology, Through 2029
Table 65 : Rest of Europe Market for Drug Discovery Technologies, by Application, Through 2029
Table 66 : Rest of Europe Market for Drug Discovery Technologies, by End User, Through 2029
Table 67 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 68 : Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 69 : Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 70 : Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2029
Table 71 : Chinese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 72 : Chinese Market for Drug Discovery Technologies, by Application, Through 2029
Table 73 : Chinese Market for Drug Discovery Technologies, by End User, Through 2029
Table 74 : Japanese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 75 : Japanese Market for Drug Discovery Technologies, by Application, Through 2029
Table 76 : Japanese Market for Drug Discovery Technologies, by End User, Through 2029
Table 77 : Indian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 78 : Indian Market for Drug Discovery Technologies, by Application, Through 2029
Table 79 : Indian Market for Drug Discovery Technologies, by End User, Through 2029
Table 80 : South Korean Market for Drug Discovery Technologies, by Technology, Through 2029
Table 81 : South Korean Market for Drug Discovery Technologies, by Application, Through 2029
Table 82 : South Korean Market for Drug Discovery Technologies, by End User, Through 2029
Table 83 : Australian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 84 : Australian Market for Drug Discovery Technologies, by Application, Through 2029
Table 85 : Australian Market for Drug Discovery Technologies, by End User, Through 2029
Table 86 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 87 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 88 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 89 : RoW Market for Drug Discovery Technologies, by Technology, Through 2029
Table 90 : RoW Market for Drug Discovery Technologies, by Application, Through 2029
Table 91 : RoW Market for Drug Discovery Technologies, by End User, Through 2029
Table 92 : RoW Market for Drug Discovery Technologies, by Sub-Region, Through 2029
Table 93 : South American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 94 : South American Market for Drug Discovery Technologies, by Application, Through 2029
Table 95 : South American Market for Drug Discovery Technologies, by End User, Through 2029
Table 96 : MEA Market for Drug Discovery Technologies, by Technology, Through 2029
Table 97 : MEA Market for Drug Discovery Technologies, by Application, Through 2029
Table 98 : MEA Market for Drug Discovery Technologies, by End User, Through 2029
Table 99 : Focus Areas in ESG Metrics
Table 100 : ESG Rankings for Drug Discovery Technologies, as of May 2024
Table 101 : Abbreviations Used in this Report
Table 102 : Report Sources
Table 103 : Agilent Technologies Inc.: Company Snapshot
Table 104 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 105 : Agilent Technologies Inc.: Product Portfolio
Table 106 : Agilent Technologies Inc.: News/Key Development, 2024
Table 107 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 108 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 109 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 110 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 111 : Bruker: Company Snapshot
Table 112 : Bruker: Financial Performance, FY 2022 and 2023
Table 113 : Bruker: Product Portfolio
Table 114 : Bruker: News/Key Developments, 2024
Table 115 : Charles River Laboratories: Company Snapshot
Table 116 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 117 : Charles River Laboratories: Service Portfolio
Table 118 : Danaher Corp.: Company Snapshot
Table 119 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 120 : Danaher Corp.: Product Portfolio
Table 121 : Danaher Corp.: News/Key Developments, 2022
Table 122 : Illumina: Company Snapshot
Table 123 : Illumina: Financial Performance, FY 2022 and 2023
Table 124 : Illumina: Product Portfolio
Table 125 : Promega Corp.: Company Snapshot
Table 126 : Promega Corp.: Product Portfolio
Table 127 : Qiagen: Company Snapshot
Table 128 : Qiagen: Financial Performance, FY 2022 and 2023
Table 129 : Qiagen: Product Portfolio
Table 130 : Qiagen: News/Key Developments, 2024
Table 131 : Revvity: Company Snapshot
Table 132 : Revvity: Financial Performance, FY 2022 and 2023
Table 133 : Revvity: Product Portfolio
Table 134 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 135 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 136 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 137 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024

List of Figures

Summary Figure : Global Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 1 : Snapshot of the Market Dynamics for Drug Discovery Technologies
Figure 2 : Most Frequent Cancer Types in Women, 2022
Figure 3 : Most Frequent Cancer Types in Men, 2022
Figure 4 : Share of Population Aged 65 and Older in G7 Countries, 2021
Figure 5 : Regional Shares of Population Aged 65+, 2016 and 2050
Figure 6 : Total Stem Cell Research Funding by the NIH, 2013-2024
Figure 7 : Process of Drug Discovery
Figure 8 : Global Market Shares of Drug Discovery Technologies, by Technology, 2023
Figure 9 : Global Market for HTS in Drug Discovery, by Region, 2021-2029
Figure 10 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, 2021-2029
Figure 11 : Global Market Shares of Genomics in Drug Discovery, by Region, 2023
Figure 12 : Global Market Shares of Proteomics in Drug Discovery, by Region, 2023
Figure 13 : Global Market Shares of Cell-based Assays and Reagents in Drug Discovery, by Region, 2023
Figure 14 : Global Market Shares of Bioinformatics in Drug Discovery, by Region, 2023
Figure 15 : Global Market Shares of Other Technologies in Drug Discovery, by Region, 2023
Figure 16 : Global Market Shares of Drug Discovery Technologies, by Application, 2023
Figure 17 : Global Market Shares of Drug Discovery Technologies in Oncology, by Region, 2023
Figure 18 : Global Market Shares of Drug Discovery Technologies in Cardiology, by Region, 2023
Figure 19 : Global Market Shares of Drug Discovery Technologies in Neurodegenerative Diseases, by Region, 2023
Figure 20 : Global Market Shares of Drug Discovery Technologies in Immunological Diseases, by Region, 2023
Figure 21 : Global Market Shares of Drug Discovery Technologies in Other Diseases, by Region, 2023
Figure 22 : Global Market Shares of Drug Discovery Technologies, by End User, 2023
Figure 23 : Global Market Shares of Drug Discovery Technologies in Biopharma Companies, by Region, 2023
Figure 24 : Global Market Shares of Drug Discovery Technologies in Research and Academia, by Region, 2023
Figure 25 : Global Market Shares of Drug Discovery Technologies in CROs, by Region, 2023
Figure 26 : Global Market for Drug Discovery Technologies, by Region, 2021-2029
Figure 27 : North American Market for Drug Discovery Technologies, by Product Type, 2021-2029
Figure 28 : North American Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 29 : North American Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 30 : North American Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 31 : U.S. Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 32 : U.S. Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 33 : U.S. Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 34 : Canadian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 35 : Canadian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 36 : Canadian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 37 : Mexican Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 38 : Mexican Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 39 : Mexican Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 40 : European Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 41 : European Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 42 : European Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 43 : European Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 44 : German Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 45 : German Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 46 : German Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 47 : U.K. Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 48 : U.K. Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 49 : U.K. Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 50 : French Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 51 : French Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 52 : French Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 53 : Italian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 54 : Italian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 55 : Italian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 56 : Spanish Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 57 : Spanish Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 58 : Spanish Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 59 : Rest of Europe Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 60 : Rest of Europe Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 61 : Rest of Europe Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 62 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 63 : Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 64 : Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 65 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 66 : Chinese Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 67 : Chinese Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 68 : Chinese Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 69 : Japanese Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 70 : Japanese Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 71 : Japanese Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 72 : Indian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 73 : Indian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 74 : Indian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 75 : South Korean Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 76 : South Korean Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 77 : South Korean Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 78 : Australian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 79 : Australian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 80 : Australian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 81 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 82 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 83 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 84 : RoW Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 85 : RoW Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 86 : RoW Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 87 : RoW Market Shares of Drug Discovery Technologies, by Sub-Region, 2023
Figure 88 : South American Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 89 : South American Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 90 : South American Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 91 : MEA Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 92 : MEA Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 93 : MEA Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 94 : Global Market Shares of Drug Discovery Technologies, by Company, 2023
Figure 95 : SWOT Analysis of the Drug Discovery Technologies Market
Figure 96 : Pillars of ESG
Figure 97 : Benefits of ESG for Companies
Figure 98 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 99 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 100 : Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 101 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 102 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 103 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 104 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 105 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 106 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 107 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 108 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 109 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 110 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 111 : Qiagen: Market Share, by Business Unit, FY 2023
Figure 112 : Qiagen: Revenue Share, by Region, FY 2023
Figure 113 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 114 : Revvity: Revenue Share, by Region, FY 2023
Figure 115 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 116 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023